Pachter, Jonathan A.,Ring, Jennifer E.,Weaver, David T.,Wang, Yan
申请号：
AU2016286091
公开号：
AU2016286091A1
申请日:
2016.06.29
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
This invention relates to methods comprising administering a FAK inhibitor and an immunotherapeutic agent such as anti-PD-1 or anti-PD-L1； that are useful in the treatment of abnormal cell growth, such as cancer, in mammals, especially humans.
